Information for "The glypican1targeted antibodydrug conjugate reveals strong growth expansion inhibition throughout glypican1positive pancreatic cancer malignancy and also esophageal squamous mobile carcinoma"
From EECH Central
Basic information
| Display title | The glypican1targeted antibodydrug conjugate reveals strong growth expansion inhibition throughout glypican1positive pancreatic cancer malignancy and also esophageal squamous mobile carcinoma |
| Default sort key | The glypican1targeted antibodydrug conjugate reveals strong growth expansion inhibition throughout glypican1positive pancreatic cancer malignancy and also esophageal squamous mobile carcinoma |
| Page length (in bytes) | 3,587 |
| Page ID | 1432160 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Marktaxi9 (Talk | contribs) |
| Date of page creation | 07:41, 3 May 2024 |
| Latest editor | Marktaxi9 (Talk | contribs) |
| Date of latest edit | 07:41, 3 May 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
